Key points from article :
Only stem cell-based products approved by FDA are hematopoietic progenitor cells derived from cord blood.
New genome engineering tools made possible to do genetics with human iPSCs and human embryonic stem cells.
Synthego has announced a partnership with the NIH to better understand the neurodegenerative disease.
Synthego has been tasked to generate iPSCs with various genomic edits, make many iPSC clones.
Diabetics might receive transplants of insulin-producing b-cells of the pancreatic islets.
Transplant material would be generated by stem cells grown in the laboratory.
Scientists were able to grow a rat pancreas, heart, and eyes in a developing mouse.
Extended pluripotent stem cells from mice can, in culture, self-organize to form blastocyst-like structures.
